In the quiet of the bear, we count the coins. But in the noise of the bull, we count the shorts. The market is euphoric, funding rates are bleeding longs, and retail is chasing memes. Yet beneath the surface, a handful of assets are being systematically shorted, ignored by analysts, and priced for failure. We have seen this pattern before—not in crypto, but in biotech. Moderna’s 177% surge in 2020 was a textbook short squeeze driven by clinical catalysts and extreme skepticism. The question is: can the same template be applied to crypto assets in a bull market? The answer is yes, but only if you understand the structural variance.
Context: The Macro Liquidity Framework The current bull run is not a repeat of 2021. It is institutional, ETF-driven, and tethered to global liquidity cycles. The Fed’s pause and the impending rate cuts are pumping M2 money supply, which historically flows into risk assets with a lag. But within crypto, the distribution is uneven. Bitcoin and Ethereum have absorbed most of the institutional inflows, while altcoins remain fragmented. The true alpha, as I learned during the ICO era, lies in the capital flows that others ignore. In 2017, I mapped whale accumulation patterns to identify tokens that would 10x before public sale. Today, the same principle applies: find the assets with high short interest, low analyst coverage, and a concrete catalyst.
This is where the Moderna template comes in. Moderna was heavily shorted, analysts were bearish, and the market was skeptical of its mRNA technology. Then a clinical trial catalyst triggered a massive short squeeze, turning the most hated stock into a 177% winner. In crypto, we have similar dynamics: tokens with high funding rates, elevated open interest, and a negative narrative. The key is to identify the catalyst that will flip the script.
Core: The Three Candidates I have screened the top 50 crypto assets by market cap and selected three that exhibit the same characteristics as Moderna: high short interest, analyst skepticism (or market indifference), and a clear technical breakout pattern with a fundamental catalyst. Let me walk through each.
1. Solana (SOL) Solana has been the most hated “Ethereum killer” since the FTX collapse. The narrative is toxic: network outages, insider token unlocks, and a perceived lack of institutional interest. Short interest on Binance and Bybit has been consistently above 15% of open interest. Funding rates have been negative for weeks, indicating that shorts are paying to maintain positions. Yet, the technicals tell a different story. SOL has formed a symmetrical triangle on the weekly chart, with a support at $120 and resistance at $175. Volume is declining, which often precedes a breakout. The catalyst? Solana’s Firedancer upgrade, which promises to increase throughput tenfold, is scheduled for Q3 2025. If it succeeds, the shorts will be forced to cover. Based on my experience in DeFi arbitrage, I know that sustainable yield often comes from regulatory arbitrage. Here, the arbitrage is between the negative narrative and the technical progress. The trigger is a weekly close above $175. Target: $260. Stop loss: $110.
2. Aave (AAVE) Aave is the blue-chip lending protocol, but its token has been a laggard. The market is obsessed with L2s and DeFi wannabes, ignoring the fact that Aave v4 is about to launch with cross-chain liquidity and a native stablecoin. Short interest on AAVE is lower than SOL, but the put/call ratio on Deribit is skewed heavily to the bearish side. Options open interest shows a wall of $150 puts, suggesting that market makers are hedging against a decline. This is a classic setup for a gamma squeeze. The technicals: AAVE has been basing between $90 and $130 since February. The Bollinger Bands are tightening, and the MACD is about to cross bullish. The catalyst is the Aave v4 proposal vote, which is expected to pass in August. If the vote passes, the protocol will unlock new revenue streams, increasing token demand. The alpha hides in the variance others ignore: while everyone is chasing low-cap DeFi tokens, the real value is in the old guard. A close above $135 triggers a breakout to $180. Stop loss: $85.
3. Chainlink (LINK) Chainlink is the most indispensable infrastructure in crypto, yet its token price has been stagnant for three years. The market has priced in the narrative that oracles are commoditized, but that ignores the upcoming CCIP (Cross-Chain Interoperability Protocol) revenue model. Short interest on LINK is moderate, but the funding rate has been consistently negative since April. The technical chart shows a massive cup-and-handle pattern on the weekly timeframe, with the handle consolidating between $12 and $16. The breakout level is $16.50. The catalyst: Chainlink is set to announce a partnership with a major traditional finance institution for tokenized asset settlement in September. This is akin to Moderna’s clinical trial data—a fundamental shift in perception. As I prepared for the Spot Bitcoin ETF due diligence, I learned that institutional adoption is the only lasting catalyst. LINK’s breakout would be a confirmation of that. Target: $28. Stop loss: $11.
Contrarian: The Decoupling Thesis The common belief in this bull market is that the entire crypto market moves together, driven by Bitcoin’s dominance. But the Moderna template suggests otherwise. The most hated assets can decouple from the macro trend and deliver outsized returns. The contrarian angle is that the shorts are not wrong—they are early. The real risk is that the catalysts fail. Intel’s CEO buy did not save the stock; Moderna’s trial data was a one-off. The same applies to crypto: if Firedancer stumbles, Aave v4 is delayed, or Chainlink’s partnership falls through, these setups will fail. The market is not a machine that rewards all short squeezes equally. We do not predict the storm; we build the hull. The hull here is a strict risk management framework: stop losses are non-negotiable, and position sizing must account for volatility. The modern crypto market is Wall Street’s toy, and Satoshi’s vision is dead. But that doesn’t mean we cannot profit from the game.
Takeaway: Positioning for the Cycle The alpha is not in chasing the hottest meme; it is in the variance others ignore. These three tokens represent a high-conviction, low-correlation bet against the market’s consensus. The bull market will eventually mature, and the liquidity will dry up. When it does, the assets with the strongest fundamentals and the most hated short positions will be the first to bounce. The question is not whether the Moderna template works—it’s whether you have the discipline to hold through the noise. In the quiet of the bear, we count the coins. In the noise of the bull, we short the sentiment.
